Seed Round - Alys Pharmaceuticals
Investment Firm
Overview
Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.
Announced Date
Feb 12, 2024
Funding Type
Seed
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Medicxi |
Round Details and Background
Alys Pharmaceuticals raised $100000000 on 2024-02-12 in Seed Round
Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 12, 2024 |  Seed Round - Alys Pharmaceuticals | 1 | - | 100.0M |
Recent Activity
There is no recent news or activity for this profile.